Ligand Pharmaceuticals Incorporated (LGND) NASDAQ

165.75

-1.31(-0.78%)

Updated at September 12 04:00PM

Currency In USD

Valuation

Market Cap1.96B
Enterprise Value1.89B
P/E Ratio-42.08
PEG Ratio-0.96
Price/Sales Ratio17.32
Price/Book Ratio3.85
Enterprise/Revenue16.04
Enterprise/EBITDA-52.68

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.4
Operating Margin-0.18

Management Effectiveness

Return On Assets-0.08
Return On Equity-0.09

Income Statement

Revenue167.13M
Revenue/Share9.74
Gross Profit156.06M
EBITDA40.79M
Net Income-4.03M
Diluted EPS-0.22

Balance Sheet

Total Cash245.02M
Total Cash/Share12.72
Total Debt5.74M
Total Debt/Equity0.01
Current Ratio5.45
Book Value Per Share43.02

Price History

52-Week Change58.2
52-Week High169.49
52-Week Low93.58
Moving Average 50 Days145.15
Moving Average 200 Days119.75

Statistics

Average Volume219,459
Shares Outstanding19.6M
% Held by Institutions97.74

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1603:1000
Last Split DateNovember 02, 2022